In the **bio-tech market**, Microsoft's stock (MSFT) seems highly fluctuating due to several reasons. The company's **Artificial Intelligence (AI)** wing is underperforming. Despite this, their record revenue has been driven by Azure AI. High expenditures on **AI** are also becoming a reason for concern. The company's cloud platform, **Azure**, has also experienced sluggish growth, thereby disappointing analysts and investors.', Expectations revolving around **intelligent cloud revenue** also fell short. Despite these drawbacks, Microsoft stocks were listed among the most reliable investment options for beginners. Analysts believe that the company's **DeepSeek AI** project has real innovations but fell short in revenue production. Lowered positions by several wealth management companies affected the stock price. Microsoft stocks remain volatile after their earnings were published. DeepSeek tests using **OpenAI** data also caused a dip in the MSFT stock. Analysts have therefore rebooted their price targets post-earnings. Despite all these concerns, some experts consider this as a buying opportunity.
Microsoft Stocks MSFT News Analytics from Fri, 20 Sep 2024 20:04:28 GMT to Sat, 01 Feb 2025 21:07:17 GMT -
Rating -4
- Innovation 3
- Information 7
- Rumor 2
